Early detection of liver, bile duct, and pancreas cancers
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study aims to find new ways to detect liver, bile duct, and pancreatic cancers early using a blood test. It may help doctors diagnose these cancers sooner, when they are easier to treat.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old
- You have a confirmed new diagnosis of liver, bile duct, or pancreatic cancer that has not yet been treated
- You have not had any cancer therapy (like surgery, chemo, or radiation) before giving the blood sample
- You are not pregnant or breastfeeding
- You have not had an organ transplant or a bone marrow/stem cell transplant
- You have not received a blood transfusion in the last 7 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.
This study looks at blood tests to find markers that may help detect and monitor pancreatic cancer. It compares people with pancreatic cancer to those with benign pancreatic conditions and healthy volunteers.
This pilot study checks whether a special blood test (ctDNA) can detect cancer signals and work as well as another sample method during biopsies for liver, bile duct, or pancreatic cancers. It may help doctors choose the best way to confirm the diagnosis from biopsy samples.
This study uses a blood test to look at how your immune system responds, which may help tell if chronic pancreatitis could turn into pancreatic cancer. It aims to find better ways to monitor people with chronic pancreatitis and catch cancer earlier.
This study uses a simple blood test (ctDNA) to learn more about the genetic makeup of advanced biliary tract cancers. It may help researchers understand how these cancers respond to treatment, and it doesn't involve any extra drugs or procedures—just blood draws.
This trial studies whether a blood-based test can help detect pancreatic cancer (or strong signs of it) earlier than usual. The goal is to see how well “liquid biopsy” results match real diagnoses and risk levels.
Hear when a new Liver Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.